Global Opioids Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Opioids Drugs

• 1.1 Definition of Opioids Drugs
• 1.2 Opioids Drugs Segment by Type
  • 1.2.1 Global Opioids Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Oxycodone
  • 1.2.3 Hydromorphone
  • 1.2.4 Codeine
  • 1.2.5 Fentanyl
  • 1.2.6 Other
• 1.3 Opioids Drugs Segment by Applications
  • 1.3.1 Global Opioids Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Pain Relief
  • 1.3.3 Anesthesia
  • 1.3.4 Other
• 1.4 Global Opioids Drugs Overall Market
  • 1.4.1 Global Opioids Drugs Revenue (2014-2025)
  • 1.4.2 Global Opioids Drugs Production (2014-2025)
  • 1.4.3 North America Opioids Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Opioids Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Opioids Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Opioids Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Opioids Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Opioids Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Opioids Drugs
• 2.3 Manufacturing Process Analysis of Opioids Drugs
• 2.4 Industry Chain Structure of Opioids Drugs

3 Development and Manufacturing Plants Analysis of Opioids Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Opioids Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Opioids Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Opioids Drugs Production and Capacity Analysis
• 4.2 Opioids Drugs Revenue Analysis
• 4.3 Opioids Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Opioids Drugs Regional Market Analysis

• 5.1 Opioids Drugs Production by Regions
  • 5.1.1 Global Opioids Drugs Production by Regions
  • 5.1.2 Global Opioids Drugs Revenue by Regions
• 5.2 Opioids Drugs Consumption by Regions
• 5.3 North America Opioids Drugs Market Analysis
  • 5.3.1 North America Opioids Drugs Production
  • 5.3.2 North America Opioids Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Opioids Drugs Import and Export
• 5.4 Europe Opioids Drugs Market Analysis
  • 5.4.1 Europe Opioids Drugs Production
  • 5.4.2 Europe Opioids Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Opioids Drugs Import and Export
• 5.5 China Opioids Drugs Market Analysis
  • 5.5.1 China Opioids Drugs Production
  • 5.5.2 China Opioids Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Opioids Drugs Import and Export
• 5.6 Japan Opioids Drugs Market Analysis
  • 5.6.1 Japan Opioids Drugs Production
  • 5.6.2 Japan Opioids Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Opioids Drugs Import and Export
• 5.7 Southeast Asia Opioids Drugs Market Analysis
  • 5.7.1 Southeast Asia Opioids Drugs Production
  • 5.7.2 Southeast Asia Opioids Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Opioids Drugs Import and Export
• 5.8 India Opioids Drugs Market Analysis
  • 5.8.1 India Opioids Drugs Production
  • 5.8.2 India Opioids Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Opioids Drugs Import and Export

6 Opioids Drugs Segment Market Analysis (by Type)

• 6.1 Global Opioids Drugs Production by Type
• 6.2 Global Opioids Drugs Revenue by Type
• 6.3 Opioids Drugs Price by Type

7 Opioids Drugs Segment Market Analysis (by Application)

• 7.1 Global Opioids Drugs Consumption by Application
• 7.2 Global Opioids Drugs Consumption Market Share by Application (2014-2019)

8 Opioids Drugs Major Manufacturers Analysis

• 8.1 Purdue Pharma
  • 8.1.1 Purdue Pharma Opioids Drugs Production Sites and Area Served
  • 8.1.2 Purdue Pharma Product Introduction, Application and Specification
  • 8.1.3 Purdue Pharma Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 J&J
  • 8.2.1 J&J Opioids Drugs Production Sites and Area Served
  • 8.2.2 J&J Product Introduction, Application and Specification
  • 8.2.3 J&J Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Teva
  • 8.3.1 Teva Opioids Drugs Production Sites and Area Served
  • 8.3.2 Teva Product Introduction, Application and Specification
  • 8.3.3 Teva Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Mylan
  • 8.4.1 Mylan Opioids Drugs Production Sites and Area Served
  • 8.4.2 Mylan Product Introduction, Application and Specification
  • 8.4.3 Mylan Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Depomed
  • 8.5.1 Depomed Opioids Drugs Production Sites and Area Served
  • 8.5.2 Depomed Product Introduction, Application and Specification
  • 8.5.3 Depomed Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 INSYS
  • 8.6.1 INSYS Opioids Drugs Production Sites and Area Served
  • 8.6.2 INSYS Product Introduction, Application and Specification
  • 8.6.3 INSYS Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Endo
  • 8.7.1 Endo Opioids Drugs Production Sites and Area Served
  • 8.7.2 Endo Product Introduction, Application and Specification
  • 8.7.3 Endo Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Pfizer
  • 8.8.1 Pfizer Opioids Drugs Production Sites and Area Served
  • 8.8.2 Pfizer Product Introduction, Application and Specification
  • 8.8.3 Pfizer Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Hikma
  • 8.9.1 Hikma Opioids Drugs Production Sites and Area Served
  • 8.9.2 Hikma Product Introduction, Application and Specification
  • 8.9.3 Hikma Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Mallinckrodt
  • 8.10.1 Mallinckrodt Opioids Drugs Production Sites and Area Served
  • 8.10.2 Mallinckrodt Product Introduction, Application and Specification
  • 8.10.3 Mallinckrodt Opioids Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pernix
• 8.12 Egalet
• 8.13 Vistapharm

9 Development Trend of Analysis of Opioids Drugs Market

• 9.1 Global Opioids Drugs Market Trend Analysis
  • 9.1.1 Global Opioids Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Opioids Drugs Regional Market Trend
  • 9.2.1 North America Opioids Drugs Forecast 2019-2025
  • 9.2.2 Europe Opioids Drugs Forecast 2019-2025
  • 9.2.3 China Opioids Drugs Forecast 2019-2025
  • 9.2.4 Japan Opioids Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Opioids Drugs Forecast 2019-2025
  • 9.2.6 India Opioids Drugs Forecast 2019-2025
• 9.3 Opioids Drugs Market Trend (Product Type)
• 9.4 Opioids Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Opioids Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List